Effect of pentoxifylline on endothelaemia and hypothalamic-pituitary-adrenocortical axis activation in female rats under stress exposure

General Physiology and Biophysics

Volumn 25, Issue 1, 2006, Pages 81-89

  Kristova, Viera ^a   Kiss, A ^b   Pirnik, Z ^b   Kriska, M ^a   Jezova, D ^b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Endothelium; Gender differences; Pentoxifylline; Stress hormones

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; PENTOXIFYLLINE; PROOPIOMELANOCORTIN;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DATA ANALYSIS; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; IMMOBILIZATION STRESS; NONHUMAN; RAT; SEX DIFFERENCE;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CELL COUNT; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HEMATOLOGIC AGENTS; HINDLIMB SUSPENSION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMOBILIZATION; IN SITU HYBRIDIZATION; PENTOXIFYLLINE; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 33744483086     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arbogast B. W., Neumann J. K., Arbogast L. Y., Leeper S. C., Kostrzewa R. M. (1994): Transient loss of serum protective activity following short-term stress: A possible biochemical link between stress and atherosclerosis. J. Psychosom. Res. 38, 871-884
2. Broadley A. J., Korszun A., Abdelaal E., Moskvina V., Jones C. J., Nash G. B., Ray C., Deanfield J., Frenneaux M. P. (2005): Inhibition of cortisol production with metyrapone prevents mental stress-induced endothelial dysfunction and baroreflex impairment. J. Am. Col. Cardiol. 46, 344-350
3. Carney R. M., Freedland K. E., Veith R. C. (2005): Depression, the autonomic nervous system, and coronary heart disease. Psychosom. Med. 67 (Suppl. 1), S29-33
4. Coe D. A., Freischlag J. A., Johnson D., Mudaliar J. H., Kosciesza S. A., Traul D. K., Chiang P. C., Cambria R. A., Seabrook G. R., Towne J. B. (1997): Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J. Surg. Res. 67, 21-25
5. de Kloet E. R. (2003): Hormones, brain and stress. Endocr. Regul. 37, 51-68
6. Doherty G. M., Jensen J. Ch., Alexander H. R., Buresh C. M., Norton J. A. (1991): Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 110, 192-198
7. Elenkov I. J., Chrousos G. P. (2002): Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N. Y. Acad. Sci. 966, 290-303
8. Graninger W., Wenisch C. (1995): Pentoxifylline in severe inflammatory response syndrome. J. Cardiovasc. Pharmacol. 25 (Suppl. 2), S134-138
9. Ghiadoni L., Donald A. E., Cropley M., Mullen M. J., Oakley G., Taylor M., O'Connor G., Betteridge J., Klein N., Steptoe A., Deanfield J. E. (2000): Mental stress induces transient endothelial dysfunction in humans. Circulation 102, 2473-2478
10. Hladovec J., Rossmann P. (1973): Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thromb. Res. 3, 665-668
11. Hornstein C. (2004): Stress, anxiety aAd cardiovascular disease: an interdisciplinary approach. Vertex 15 (Suppl. 1), S21-31 (in Spanish)
12. Huang A., Kaley G. (2004): Gender-specific regulation of cardiovascular function: Estrogen as key player. Microcirculation 11, 9-38
13. Jezova D. (2004): Gender differences in the stress response and in the action of antidepressant drugs. Psychiatrie pro praxi 5, 136-138 (in Czech)
14. Jezova D. (2005): Control of ACTH secretion by excitatory amino acids: functional significance and clinical implications. Endocrine 28, 287-294
15. Jezova D., Guillaume V., Jurankova E., Carayon P., Oliver C. (1994): Studies on the physiological role of ANF in ACTH regulation. Endocr. Regul. 28, 163-169
16. Jezova D., Jurankova E., Mosnarova A., Kriska M., Skultetyova I. (1996): Neuroendocrine response during stress with relation to gender differences. Acta Neurobiol. Exp. (Wars.) 56, 779-785
17. Jezova D., Ochedalski T., Kiss A., Aguilera G. (1998): Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocorticai activation during stress. J. Neuroendocrinol. 10, 67-72
18. Jezova D., Kristova V., Slamova J., Mlynarik M., Pirnik Z., Kiss A., Kriska M. (2003): Stress-induced rise in endothelaemia, von Willebrand factor and hypothalamic-pituitary-adrenocortical axis activation is reduced by pretreatment with pentoxifylline. J. Physiol. Pharmacol. 54, 329-338
19. Kwiecien S., Brzozowski T., Konturek P. C., Pawlik M. W., Pawlik W. W., Kwiecien N., Konturek S. J. (2004): Gastroprotection by pentoxifylline against stress-induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokines. J. Physiol. Pharmacol. 55, 337-355
20. Samlaska C. P., Winfield E. A. (1994): Pentoxifylline. J. Am. Acad. Dermatol. 30, 603-621
21. Sherwood A., Johnson K., Blumenthal J. A., Hinderliter A. L. (1999): Endothelial function and hemodynamic responses during mental stress. Psychosom. Med. 61, 365-370
22. Sikora J. P. (2000): The role of cytokines and reactive oxygen species in the pathogenesis of sepsis. Pol. Merkuriusz Lek. 7, 47-50 (in Polish)
23. Sinzinger H. (1983): Pentoxifylline enhances formation of prostacyclin from rat vascular and renal tissue. Prostaglandins Leukot. Med. 12, 217-226
24. Skultetyova I., Kiss A., Jezova D. (1998): Neurotoxic lesions induced by monosodium glutamate result in increased adenopituitary proopiomelanocortin gene expression and decreased corticosteroneclearance in rats. Neuroendocrinology 67, 412-420
25. Szöcs K. (2004): Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen. Physiol. Biophys. 23, 265-295
26. Spieker L. E., Luscher T. F., Noll G. (2001): Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis. J. Cardiovasc. Pharmacol. 38 (Suppl. 2), S35-41
27. Strawn W. B., Bondjers G., Kaplan J. R., Manuck S. B., Schwenke D. C., Hansson G. K., Shively C. A., Clarkson T. B. (1991): Endothelial dysfunction in response to psychosocial stress in monkeys. Circ. Res. 68, 1270-1279